The Indirect Cost Rate War: How Universities, Courts, and Congress Beat Back the 15% Overhead Cap

A research university receiving $100 million a year in NIH grants typically recovers about $55 million in indirect costs — money that pays for the buildings, utilities, compliance staff, IT infrastructure, and administrative systems that make federally funded research possible. Under a policy the Trump administration attempted to impose across four major agencies, that $55 million would have dropped to $15 million. Overnight.

The 18-month fight over indirect cost rates has been the most consequential battle over research funding mechanics since the creation of the Uniform Guidance in 2013. It involved executive orders, agency-level policy announcements, emergency court injunctions, a federal appeals ruling, dueling Congressional appropriations riders, and a higher education coalition scrambling to propose an alternative framework before the government imposed one. By early 2026, universities had won — for now. But the victory is provisional, the underlying tensions are unresolved, and every institution managing federal awards needs to understand what happened, what was blocked, and what's likely coming next.

Four Agencies, One Number: 15%

The offensive began on February 7, 2025, when NIH issued Notice NOT-OD-25-068 implementing a flat 15% indirect cost rate on all new and existing grants to institutions of higher education, effective three days later. The notice bypassed the negotiated rate system that had governed university overhead reimbursements for decades — a system in which each institution's actual facilities and administrative costs are audited and a rate is set through formal negotiation with a cognizant federal agency, typically HHS or DOD.

Within weeks, the Department of Energy followed. On April 11, 2025, DOE announced it would cap indirect costs at 15% for all grants to colleges and universities, claiming annual savings of $405 million. DOE distributes over $2.5 billion annually across more than 300 institutions, and the department framed the move as eliminating "inefficient spending" on "administrative costs and facility upgrades" rather than direct research. The National Science Foundation and Department of Defense issued similar policies.

The 15% threshold wasn't arbitrary — it's the de minimis rate in government-wide regulations, the floor offered to organizations that have never negotiated a rate. Using it as the ceiling meant treating Harvard Medical School the same as a first-time grantee with no research infrastructure to maintain.

The financial impact was staggering. Negotiated rates at major research universities typically range from 50% to 67% of modified total direct costs. The Association of American Universities estimated that a sector-wide cap at 15% would strip roughly $12 billion annually from university budgets. For individual institutions, the math was brutal: a university with a 55% negotiated rate receiving $100 million in NIH funding would lose $40 million per year in overhead recovery. That money doesn't fund luxury — it covers building depreciation, lab maintenance, hazardous waste disposal, IRB operations, grant accounting offices, research compliance teams, and the cybersecurity infrastructure that federal agencies themselves require grantees to maintain.

The Courts Stepped In Fast

The legal response was immediate. Multiple universities and higher education associations filed for emergency relief, arguing that the agencies had bypassed required rulemaking procedures under the Administrative Procedure Act and violated existing negotiated rate agreements.

On February 21, 2025, a federal judge extended a temporary restraining order blocking NIH's implementation. The case moved quickly through the courts. By January 5, 2026, a federal appeals court in Massachusetts ruled definitively that NIH could not unilaterally cap indirect rates at 15%, finding that the agency had exceeded its statutory authority by attempting to impose a blanket rate change without proper notice-and-comment rulemaking.

The ruling was narrowly scoped to NIH but sent a clear signal to the other agencies. DOE's implementation, which had included language threatening to terminate existing grants that didn't conform to the new rate, faced similar legal vulnerability. The court's reasoning — that negotiated rate agreements carry contractual weight and cannot be unilaterally rewritten — applied with equal force to DOE, NSF, and DOD policies.

Congress Drew the Line

While courts provided emergency relief, the definitive block came through appropriations. When Congress assembled the Consolidated Appropriations Act for fiscal year 2026 — signed into law in late January 2026 — it included explicit language prohibiting changes to the existing indirect cost reimbursement system across every major research-funding agency.

The provisions covered NIH, DOE, DOD, NSF, NASA, the Commerce Department, and the Office of Management and Budget itself. OMB was specifically directed not to modify the indirect cost framework — a significant move, since OMB controls the Uniform Guidance (2 CFR 200) that governs indirect cost policies government-wide. The appropriations language didn't just block the 15% cap; it froze the entire rate-setting system in place for fiscal year 2026, preventing any agency from implementing alternative approaches without future Congressional authorization.

The bipartisan nature of the block was notable. Leadership in both parties supported maintaining negotiated rates, reflecting the geographic distribution of research university spending — federal research dollars flow into virtually every Congressional district, and the facilities and jobs that indirect cost recovery supports are tangible local economic assets.

But the accompanying committee reports included a telling caveat: they acknowledged "room for improvement" in the current system and directed agencies to study — but not implement — alternative approaches. The status quo was preserved, but Congress signaled it wouldn't defend it indefinitely.

FAIR: The University Counter-Proposal

Universities recognized that simply blocking the cap wasn't a long-term strategy. The administration's core argument — that indirect cost rates are opaque, vary wildly between institutions, and subsidize administrative bloat rather than research — resonated with enough lawmakers and taxpayers to pose a persistent threat.

In response, the Joint Associations Group on Indirect Costs — a coalition of higher education organizations including NACUBO, AAU, and APLU — developed the FAIR framework: Financial Accountability in Research. FAIR made its public debut in July 2025 and represents the sector's attempt to propose reforms on its own terms before the government imposes them.

The framework's details are still being refined, but its core premise is transparency: standardized reporting of what indirect cost recovery actually funds, benchmarking across peer institutions, and clearer connections between overhead spending and research outcomes. FAIR aims to demonstrate that the current system, while imperfect, reflects real costs — and that a flat rate would simply shift those costs from the federal government to state taxpayers, tuition-paying students, and university endowments.

The Joint Associations Group has indicated its intention to work with Congress on implementing elements of FAIR for fiscal year 2027 appropriations. Whether that timeline holds depends on whether the administration renews its push for caps when the current appropriations expire on September 30, 2026.

What This Means for Grant Seekers Right Now

For fiscal year 2026, the practical answer is straightforward: negotiated rates are intact. Institutions should continue budgeting grants at their established rates, and agencies are processing awards accordingly.

But several dynamics deserve attention:

Executive Order 14332 adds pressure from a different angle. Even with indirect cost caps blocked, the executive order on federal grantmaking oversight directs agencies to show "preference for institutions with lower indirect cost rates" in award decisions. That language doesn't cap rates, but it creates a competitive disadvantage for institutions with higher overhead. If two proposals score equally and one comes from a university charging 58% overhead while the other charges 35%, the executive order tips the scale. Researchers at high-overhead institutions should discuss this dynamic with their sponsored programs offices — some universities are exploring voluntary rate reductions on competitive applications.

DOE's threat to terminate non-conforming grants was never formally rescinded. The appropriations language blocks implementation of the 15% cap, but DOE's original policy announcement included language about terminating existing grants. Whether that threat carries any residual legal weight is an open question that university counsel offices should be monitoring.

The FY2027 fight starts this summer. The current appropriations blocking language expires September 30, 2026. If the administration includes indirect cost cap proposals in its FY2027 budget request — likely — universities will need to mount the same Congressional campaign again. The FAIR framework's reception on Capitol Hill will determine whether the sector has a proactive story to tell or is simply playing defense for another cycle.

Smaller institutions face asymmetric risk. The indirect cost rate debate is often framed as a battle between the federal government and wealthy research universities. But the institutions most vulnerable to rate disruption are mid-tier research universities and minority-serving institutions whose research infrastructure depends heavily on overhead recovery. A university with a $5 billion endowment can absorb a temporary funding gap. A historically Black university whose entire research computing infrastructure is funded through indirect cost recovery cannot.

The Deeper Tension

The indirect cost fight exposed a fundamental disagreement about what federal research funding is buying. The administration's position — that taxpayer dollars should fund experiments, not buildings — has intuitive appeal. The university position — that experiments require buildings, and buildings require maintenance, and maintenance requires money — is factually correct but harder to communicate in a political environment suspicious of institutional spending.

Both sides have legitimate points. Indirect cost rates have increased over decades, and the negotiation process is genuinely opaque to outsiders. Some institutions have used overhead recovery to fund activities only loosely connected to research. At the same time, the 15% figure was never based on an analysis of what research infrastructure actually costs — it was a political number chosen for its simplicity and its savings, not its relationship to reality.

The next chapter will be written in FY2027 appropriations negotiations, where the FAIR framework will get its first real test. Universities that can demonstrate exactly what their indirect cost dollars fund — with the kind of transparency that withstands Congressional scrutiny — will be in the strongest position. Those that can't will find the 15% cap argument waiting for them again.

For researchers navigating an environment where overhead rates have become a competitive factor in award decisions, tools like Granted can help you identify opportunities where your institution's cost structure is an advantage rather than a liability.